-
Don't Worry Spec. Pharma Investors, Drug Pricing Legislation Probably Won't Affect You
Monday, October 5, 2015 - 3:06pm | 502Read More...After speaking with industry insiders and legal experts, Leerink believes that the selloff in pharmaceutical stocks is overdone. Experts see “near zero odds” that Hillary Clinton’s drug pricing plan will become law without significant changes. Leerink believes that the most...
-
Leerink Upgrades Vocera Communications Following Proprietary Survey
Monday, August 31, 2015 - 2:28pm | 302Read More...Shares of Vocera Communications Inc (NYSE: VCRA) spiked higher by more than 7 percent Monday after analysts at Leerink upgraded the stock. David Larsen, Leerink's Health Care Services analyst, upgraded Vocera to Outperform from Market Perform with an unchanged $14 price target following a...
-
A 'Pivotal Binary Event' Is Coming For Healthcare Stocks
Thursday, March 5, 2015 - 12:29pm | 388Read More...In a report published Thursday, Leerink analyst Ana Gupte, Ph.D. detailed a conference call with MEDACorp specialists following the Supreme Court's oral arguments on the challenge to the Federal Exchange Subsidies. Speaking to Gupte included a former D-House Representative as well as an...
